Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap21.63B
Enterprise Value22.08B
GH
(NASDAQ)Guardant Health, Inc.
$162.78-- (--)
Loading... - Market loading
Guardant Health (GH) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)18.28
Forward Price/Sales12.81
Price/Book (mrq)-97.04
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue18.66
EV/Earnings-48.69
EV/EBITDA-52.35
EV/EBIT-46.86
EV/FCF-91.71
Stock Price
Current price, 52-week range, and moving averages
Current Price$162.78
1-Day Change1.12%
52-Week High$176.58
52-Week Low$53.40
52-Week Change173.86%
YTD Change60.00%
1-Year Change187.75%
50-Day MA$159.94
200-Day MA$118.03
Avg Volume (30 day)2.13M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding132.87M
Book Value per Share$-1.68
Net Cash per Share$-3.38
FCF per Share$-1.81
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$180.35
Target Upside/Downside10.79%
Analyst ConsensusBuy
Analyst Count23
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin65.01%
EBITDA Margin (ttm)-35.64%
EBIT Margin (ttm)-39.82%
Operating Margin (ttm)-39.75%
Pretax Margin (ttm)-38.41%
Profit Margin (ttm)-38.33%
FCF Margin (ttm)-20.35%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Assets (ttm)-23.71%
Return on Invested Capital (ttm)-164.25%
Return on Capital Employed (ttm)-29.95%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue1.18B
Gross Profit769.16M
Operating Income-470.26M
Pretax Income-454.47M
Net Income-453.44M
EBITDA-421.70M
EBIT-471.15M
Diluted EPS$-3.50
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow-185.19M
Capital Expenditures55.54M
Free Cash Flow-240.72M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth42.74%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)1.91B
Cash & Securities (mrq)1.05B
Net Cash (mrq)-449.47M
Net Cash per Share$-3.38
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)1.50B
Working Capital (mrq)1.03B
Total Equity (mrq)-222.87M
Book Value per Share$-1.68
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)4.03
Quick Ratio (mrq)3.71
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield-2.10%
FCF Yield-1.11%
Buyback Yield-1.69%
Total Shareholder Yield-1.69%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score-3.75
Piotroski F-Score4/9
Frequently Asked Questions About Guardant Health Statistics
What are the key financial metrics for GH?
Guardant Health, Inc. (GH) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is GH's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Guardant Health is overvalued or undervalued.
How do I read GH's profitability ratios?
Guardant Health's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do GH's debt ratios indicate?
The financial health section shows Guardant Health's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is GH's dividend analysis?
The dividend section covers Guardant Health's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.